Physician profile
Jacob Nelson
NPI 1598266801
$1,416.06
in general payments reported to CMS, 2019-2025
11 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.52 · 2020: $20.85 · 2021: $230 · 2022: $296 · 2023: $287 · 2024: $399 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $808.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $619.96 | 2021-2024 | |
| Glaxosmithkline, LLC. | $233.79 | 2021-2022 | |
| Hologic Sales and Service, LLC | $139.21 | 2019-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Astellas Pharma US INC | $125.00 | 2023 | Veozah |
| Smith+Nephew, INC. | $124.36 | 2024 | Pico 7 |
| Avanos Medical | $72.41 | 2023 | On-Q* Pump and Accessories |
| Boston Scientific Corporation | $36.88 | 2022 | |
| Abbvie INC. | $20.85 | 2020 | |
| Ethicon US, LLC | $16.07 | 2019 | |
| Ferring Pharmaceuticals INC. | $15.24 | 2019 | |
| Galen US INC | $12.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.